Sexual Differences in pERK/ERK due to 17-Beta-Estradiol Treatments

Simple item page
dc.contributor.advisorBryant, Damani
dc.contributor.authorFerrise, Daniel F.
dc.date.accessioned2015-01-26T20:53:28Z
dc.date.available2015-01-26T20:53:28Z
dc.date.issued2014-04
dc.descriptionColor poster with text, images, and graphs.en
dc.description.abstractAlzheimer's disease is an important disease, affecting both women and men. One area of study is the effect of 17-beta-Estradiol (E2) on neuroprotection. Females have a sharp increase in Alzheimer's onset following menopause. The purpose of this study was to determine where the cell signaling differences inlay.en
dc.description.sponsorshipNational Science Foundation; University of Wisconsin--Eau Claire Office of Research and Sponsored Programs.en
dc.identifier.urihttp://digital.library.wisc.edu/1793/70275
dc.language.isoen_USen
dc.relation.ispartofseriesUSGZE AS589en
dc.subject17 beta-estradiolen
dc.subjectAlzheimer's diseaseen
dc.subjectNeuroprotection--Sex differenceen
dc.subjectMenopauseen
dc.subjectPostersen
dc.titleSexual Differences in pERK/ERK due to 17-Beta-Estradiol Treatmentsen
dc.typePresentationen

Files

Original bundle

Now showing 1 - 2 of 2
Thumbnail Image
Name:
FerriseSpr14.pdf
Size:
234.44 KB
Format:
Adobe Portable Document Format
Download
Thumbnail Image
Name:
FerriseSpr14.pptx
Size:
1.12 MB
Format:
Unknown data format
Download

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
2.03 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Student Research Day